CATX R&D Expenses
Perspective Therapeutics Inc · R&D Expenses
CATX R&D Expenses
Latest reported$95.05Mperiod ending
CATX R&D Expenses ($0.00 → $95.05M)
Annual R&D Expenses
High-resolution chart · PNG
CATX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 84,215,000 | |
| 39,332,000 | |
| 21,311,000 | |
| 1,813,000 | |
| 2,582,000 | |
| 1,427,000 | |
| 1,126,000 | |
| 1,474,000 | |
| 1,746,000 | |
| 965,000 | |
| 528,049 | |
| 614,771 | |
| 668,803 | |
| 627,107 | |
| 730,579 | |
| 465,333 | |
| 340,959 | |
| 958,665 | |
| 1,358,075 | |
| 1,345,163 | |
| 450,425 | |
| 137,532 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |